Algebris (Uk) LTD Genenta Science S.P.A. Transaction History

Algebris (Uk) LTD

  • $216 Million
  • Q3 2024

A detailed history of Algebris (Uk) LTD transactions in Genenta Science S.P.A. stock. As of the latest transaction made, Algebris (Uk) LTD holds 45,000 shares of GNTA stock, worth $242,100. This represents 0.09% of its overall portfolio holdings.

Number of Shares
45,000
Previous 45,000 -0.0%
Holding current value
$242,100
Previous $139,000 38.13%
% of portfolio
0.09%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$3.93 - $5.88 $176,850 - $264,600
45,000 New
45,000 $247,000
Q2 2022

Aug 17, 2022
SELL
$5.39 - $8.26 $242,550 - $371,700
-45,000 Closed
0 $0
Q4 2021

Feb 15, 2022
BUY
$10.96 - $11.87 $493,200 - $534,150
45,000 New
45,000 $493,000

Others Institutions Holding GNTA

# of Institutions
5
Shares Held
248K
Call Options Held
0
Put Options Held
0
View Full List

About Genenta Science S.p.A.

GNTA Quotes by TradingView
  • Ticker GNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,216,900
  • Market Cap $98M
  • Description
  • Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated...
More about GNTA
Track This Portfolio

Track Algebris (Uk) LTD Portfolio

Follow Algebris (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algebris (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Algebris (Uk) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email